App-Quantinova.ai

Characterization of Endothelial Colony-forming Cells Bioactivity in Young Adults Born Extremely Preterm Versus Term

Katryn Paquette - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Infant Respiratory Distress Syndrome

N/A

Correlation of Early Echocardiographic Right Ventricular Dimension and MRI Right Ventricular Volumes Late After Tetralogy of Fallot Repair

Osman Al-Radi - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Tetralogy of fallot

N/A

Left Ventricular Dysfunction in Children and Adolescents with Arrhythmogenic Right Ventricular Cardiomyopathy

Robert Hamilton - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmogenic right ventricular cardiomyopathy

N/A

Atrial Fibrillation is Associated with Increased Atrial Metabolic Activity on FDG/PET Imaging in Patients with Ischemic Cardiomyopathy

Rob Beanlands - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ischemic cardiomyopathy

N/A

Left Atrial Dysfunction in Patients with Anderson - Fabrys Disease Using Magnetic Resonance Imaging Derived Left Atrial Phasic Function

Qin Li - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left ventricular hypertrophy

alpha-galactosidase

Inflammation Imaged with [18F]-FDG PET/CTA is Related to 3D Ultrasound Phenotypes of High-risk Carotid Plaque: Sub-study of the Canadian Atherosclerosis Imaging Network (CAIN-2)

Aaron Fenster - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Sex Differences in Growth Rates of Thoracic Aortic Aneurysms

Munir Boodhwani - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Dyslipidemia

N/A

Cardiac-targeted Therapy with Cardiotrophin-1 Rescues Defective Right Ventricular Adaptation in Severe Pulmonary Arterial Hypertension in Fischer Rats

Mohammad Abdul-Ghani - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

cardiotrophin-1

Abrogation of S100A1 Exacerbates Right Ventricular Dilation and Fetal Gene Expression in the Sugen/hypoxia Model of Pulmonary Arterial Hypertension in Mice

James N Tsoporis - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

miR-223 Regulates DNA Damage Signaling in Pulmonary Arterial Hypertension

Marie Le Guen - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pulmonary arterial hypertension

Monocrotaline

Improved Assessment of CAD in Women with Flurpiridaz F-18 PET Myocardial Perfusion Imaging: Results of Subset Analysis of the Flurpiridaz F-18 Phase 3 Study

Jamshid Maddahi - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

flurpiridaz F 18

Lipoprotein(a) Catabolism and Apolipoprotein(a) Secretion is Regulated by Sortilin

Matthew Gemin - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Circulating MicroRNAs Provide Insight into Potential Molecular Links Between Hypertensive Disorders of Pregnancy and Cardiovascular Disease

Kenny Schlosser - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Pregnancy-Induced Hypertension

N/A

Deletion of AT2 Receptor Prevents SHP-1 Expression and Improves Blood Flow in Diabetic Ischemic Hindlimb

Andreanne Guay - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Peripheral artery disease

Angiotensin II

MicroRNA Regulation of JAK-STAT System in the Atrial Fibrillation-related Fibrotic Response

Sirirat Surinkaew - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Becaplermin

The Impact of a Positive Gene Test on Presentation and Disease Progression of Arrhythomogenic Right Ventricular Cardiomyopathy in Childhood

Robert Hamilton - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmogenic right ventricular cardiomyopathy

N/A

Human Leukocyte Antigen-G Polymorphisms Association to Post Heart Transplant Cardiac Allograft Vasculopathy

Livia Goldraich - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac allograft vasculopathy

N/A

Myocardial Replenishment of Tissue Inhibitor of Metalloproteinase (TIMP)-3 and TIMP4 Following Myocardial Infarction Result in Differential Protective Effects

Ratnadeep Basu - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

TIMP-3 secretion inducer

Over-expression of NDNF Rejuvenates Aged Human Mesenchymal Stem Cells and Improves Mouse Heart Function After Myocardial Infarction

Shu-hong Li - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Predictors of Net Adverse Cardiovascular Events in Patients on Triple Antithrombotic Therapy

Angel Fu - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Acute Coronary Syndromes

Clopidogrel bisulfate

Filters

28841 Abstracts